SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 142 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $463,000 | -79.0% | 47,191 | -76.9% | 0.01% | -79.7% |
| Q4 2016 | $2,206,000 | +10.3% | 204,316 | +4.7% | 0.06% | +1.7% |
| Q3 2016 | $2,000,000 | -4.1% | 195,162 | +22.3% | 0.06% | -6.5% |
| Q2 2016 | $2,085,000 | +32.6% | 159,545 | +11.6% | 0.06% | +29.2% |
| Q1 2016 | $1,572,000 | +23.1% | 142,945 | +3.0% | 0.05% | +33.3% |
| Q4 2015 | $1,277,000 | -25.8% | 138,753 | -44.1% | 0.04% | -30.8% |
| Q3 2015 | $1,722,000 | -58.1% | 248,116 | -40.7% | 0.05% | -57.7% |
| Q2 2015 | $4,105,000 | +20.6% | 418,073 | +8.8% | 0.12% | +18.3% |
| Q1 2015 | $3,404,000 | +35.5% | 384,222 | +33.9% | 0.10% | +16.9% |
| Q4 2014 | $2,513,000 | +27.2% | 286,885 | +0.1% | 0.09% | +21.9% |
| Q3 2014 | $1,976,000 | +13073.3% | 286,492 | +8707.0% | 0.07% | +7200.0% |
| Q1 2014 | $15,000 | -90.6% | 3,253 | -89.8% | 0.00% | -85.7% |
| Q4 2013 | $160,000 | -73.4% | 31,753 | -73.3% | 0.01% | -74.1% |
| Q3 2013 | $602,000 | – | 119,014 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|